Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective

This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Atopic Dermatitis Burden Caregiver Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Eczema Eczema Atopic Dermatitis Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged ≥18 years;
Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis;
Able to read and understand French or English;
Willing and able to provide written informed consent.

Exclusion criteria

Caregivers whose child has been diagnosed with severe atopic dermatitis ;
Caregivers whose child is currently treated with oral or topical Janus Kinase Inhibitor);
Caregivers whose child is currently participating in a clinical trial for atopic dermatitis;
Other parent or caregiver within the household of the child with atopic dermatitis.

Treatment and study plan

No Intervention: Observational Cohort

Other

No specific intervention is assess in this study. Observational cohort.

Primary outcomes

To estimate work productivity loss in caregivers of children with mild or moderate atopic dermatitis.

Time frame: At recruitment

Using the Work Productivity and Activity Impairment questionnaire. This questionnaire provides a quantitative measure of impairment over the last 7 days and includes four metrics: absenteeism (work time missed because of health issues during the past 7 days), presenteeism (impairment while working due to health issues during the past 7 days), overall work productivity loss (combination of absenteeism and presenteeism), and activity impairment.

Secondary outcomes

To estimate family burden of mild to moderate atopic dermatitis in children, as reported by caregivers

Time frame: At recruitment

The Dermatitis Family Impact (DFI) questionnaire will be administered to caregivers to evaluate the family burden of pediatric atopic dermatitis. The DFI is a validated, 10-item instrument specifically developed for atopic dermatitis, covering domains such as housework, feeding, sleep, leisure activities, time spent shopping, expenditure, physical fatigue, emotional distress, relationships, helping with treatment, with a 7-day recall period. Each item is scored on a 4-point Likert scale ("Not at all = 0" to "Very much = 3"), with higher total scores indicating greater impact

Study contacts

Contact information is provided by the study sponsor or research team.

Jean Lachaine, Ph. D.

CONTACT

[email protected]

514-731-8207

Sponsors and collaborators

Lead sponsor

PeriPharm

Other

Registry information

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Jan 7, 2026
Registry last updated: Jan 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting